Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukemia (Relapsed/Refractory)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03896854
What this trial is testing

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 15
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT03765541
What this trial is testing

Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
University Hospital, Toulouse 73
Not applicableNot Yet RecruitingNCT06686173
What this trial is testing

Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT

Who this might be right for
High-Risk Acute Myeloid LeukemiaRelapse And/or Refractory AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 114
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Ended earlyNCT04637009
What this trial is testing

TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms

Who this might be right for
Acute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm
Astex Pharmaceuticals, Inc. 20
Early research (Phase 1)Ended earlyNCT02675452
What this trial is testing

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Acute Myeloid Leukemia
Amgen 141
Large-scale testing (Phase 3)Looking for participantsNCT05183035
What this trial is testing

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
PedAL BCU, LLC 130
Testing effectiveness (Phase 2)Study completedNCT00334074
What this trial is testing

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
Baylor Research Institute 30
Early research (Phase 1)Study completedNCT00301938
What this trial is testing

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+23 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT04789408
What this trial is testing

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Kite, A Gilead Company 15
Testing effectiveness (Phase 2)Study completedNCT02686593
What this trial is testing

Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia
The University of Hong Kong 50
Early research (Phase 1)Ended earlyNCT03135028
What this trial is testing

Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults

Who this might be right for
Hematologic MalignancyAcute Myeloid Leukemia
Gilead Sciences 9
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)UnknownNCT04272125
What this trial is testing

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute
Chongqing Precision Biotech Co., Ltd 40
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Ended earlyNCT03063203
What this trial is testing

Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia, Relapsed, Adult
Washington University School of Medicine 17
Early research (Phase 1)Ended earlyNCT02109627
What this trial is testing

Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML

Who this might be right for
Acute Myeloid LeukemiaRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
C. Babis Andreadis 17
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Next Page